Xtl Biopharmaceuticals (XTLB) Interest Coverage Ratio Growth (3y) (2012 - 2018)
Xtl Biopharmaceuticals (XTLB) Interest Coverage Ratio Growth (3y) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 42.15% |
| Sep 30, 2018 | 313.42% |
| Jun 30, 2018 | 11.40% |
| Mar 31, 2018 | -11.98% |
| Dec 31, 2017 | -29.66% |
| Sep 30, 2017 | -70.16% |
| Mar 31, 2017 | 26.08% |
| Dec 31, 2016 | -56.80% |
| Sep 30, 2016 | 69.79% |
| Jun 30, 2016 | -28.61% |
| Mar 31, 2016 | 48.29% |
| Dec 31, 2015 | -3.46% |
| Sep 30, 2015 | 65.21% |
| Jun 30, 2015 | -41.60% |
| Mar 31, 2015 | -15.93% |
| Dec 31, 2014 | 63.88% |
| Sep 30, 2014 | 29.80% |
| Mar 31, 2014 | -2.19% |
| Jun 30, 2013 | 45.05% |
| Mar 31, 2013 | 31.53% |